4//SEC Filing
RABBANI ELAZAR 4
Accession 0000930413-19-000022
CIK 0000316253other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:58 PM ET
Size
5.6 KB
Accession
0000930413-19-000022
Insider Transaction Report
Form 4
RABBANI ELAZAR
DirectorChairman and CEO
Transactions
- Award
Stock Option (to acquire common stock)
2019-01-03+128,000→ 222,249 totalExercise: $2.80From: 2020-01-04Exp: 2024-01-02→ Common Stock (128,000 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted 128,000 stock options. The options have a five-year term and shall vest in two equal annual tranches, beginning January 4, 2020.
- [F2]Does not include 25,000 Restricted Stock Units granted to the Reporting Person on January 3, 2019, which will vest, if at all, based upon (i) achievement of average revenue growth and adjusted EBITDA growth goals on January 3, 2022, and (ii) the continued service of the Reporting Person through January 3, 2022.
Documents
Issuer
ENZO BIOCHEM INC
CIK 0000316253
Entity typeother
Related Parties
1- filerCIK 0000903568
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:58 PM ET
- Size
- 5.6 KB